RecruitingNot ApplicableNCT06977360

Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research Proposal


Sponsor

National Cancer Centre, Singapore

Enrollment

40 participants

Start Date

May 23, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The overall aim of the study is to evaluate the feasibility, acceptability and preliminary effects of the next iteration of iCareBreast+, an innovative breast care e-support intervention programme, by refining existing contents and building new contents based on comprehensive assessment of breast cancer women's needs and preferences among breast cancer patients undergoing chemotherapy. The specific objectives of this study are: 1. To develop a new iteration of an innovative smartphone-based self-care solution for patients with breast cancer undergoing chemotherapy (iCareBreast+); 2. To assess the feasibility and acceptability of iCareBreast+; and 3. To explore the preliminary effects of iCareBreast+ on the primary outcome of self-efficacy, and knowledge of breast cancer treatment, as well as secondary outcomes including anxiety, depression, health-related quality of life (HRQoL), social support and satisfaction with oncologic care.


Eligibility

Sex: FEMALEMin Age: 21 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a digital support program designed to help women with breast cancer manage the emotional and practical challenges of chemotherapy. The program is delivered through a smartphone app and includes tools for tracking wellbeing, accessing resources, and connecting with support. **You may be eligible if...** - You are a woman aged 21 or older - You have been diagnosed with stage 1, 2, or 3 breast cancer - You are starting chemotherapy for the first time (or are within your first 4 cycles) - You can speak, read, and write in English or Mandarin - You have access to a smartphone **You may NOT be eligible if...** - You have or have had another type of cancer - You have a history of psychiatric illness, anxiety disorder, mood disorder, or cognitive impairment - You have had issues with alcohol or substance use in the past year - You are already participating in another psychological support program - You are pregnant - You have experienced a bereavement in the past 6 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRoutine care

Routine care provided by NCCS

OTHERRoutine care + iCareBreast+ mobile app

Routine care provided by NCCS (identical to the control group) along with access to the iCareBreast+ mobile app


Locations(1)

National Cancer Centre, Singapore

Singapore, Singapore

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06977360


Related Trials